Global Head of Fundamental Equity
• Quarterly outlook
Equity outlook: Lovely liquidity
It’s been a stunning 2024 for equities, led by the US, but emerging markets also delivered solid gains and may be primed for more in 2025 if Trump trade dispute fears can be overcome.
Authors
Head of Emerging Markets team
Summary
- Equity market strength surprised in 2024, with the US and China both beating expectations
- Our Global Stars team benefited from the AI-driven rally and some unheralded quality gems
- We are positive on EM in 2025 once potential Trump tariffs move to a negotiation phase
For the last 25 years I have organized investment forecasting games in the office. Usually, around 60% of participating colleagues are on the right side of the market. This year has been exceptional, as the vast majority of participants have underestimated the strength of the markets. The S&P 500, Chinese equities, Magnificent Seven stocks and credit spreads have all performed much better than was anticipated at the beginning of the year. The number of risks seemed endless: market concentration, highly valued technology stocks, prolonged inflation with a Fed behind the curve, China in the doldrums, just to name a few. Who would have expected one of the strongest equity markets of this century, with almost 30% return [MSCI World in EUR on 16 December] at the time of writing? Stanley Druckenmiller’s investment adage was once again proven true: it’s liquidity that moves markets. Particularly so when the real economy has a limited number of projects to absorb the (excess) capital.
Luckily, our Fundamental Equity teams looked beyond the risks and captured opportunities across the spectrum. The Global Stars team kept the foot on the pedal of large-cap technology stocks and benefited from the AI-powered rally. That took courage; good value is not always to be found in cheap stocks. At the same time the team invested in multiple other successful companies, such as Trane Technologies, Deutsche Telecom and Paypal. The performance record of the Global Stars strategy relative to the benchmark is very strong over a 1-, 3-, 5- and 10-year horizon, and we welcomed numerous new clients over the course of 2024. The portfolio positioning looks promising for 2025.
Emerging markets are up a healthy 15% year-to-date. The strong relative performance of our Asia-Pacific strategies is particularly worth noting. We are expanding the team to research the next wave of great stock opportunities. While emerging market returns may seem a bit pale compared to those in developed markets, Wim-Hein Pals explains in his outlook that there are plenty of good prospects across the various regions for 2025, at exceptionally low valuations. We believe there is a good chance that sentiment toward emerging markets may change after the new US administration takes over, when the discussion around tariffs will likely shift from threats to deals. We are completing our 2024 campaign ‘30 years of investing in Emerging Markets at Robeco’ with positive expectations.
With liquidity still abundant, best wishes for successful investments in 2025!
Download the publication
Important information
THIS WEBSITE IS SOLELY INTENDED FOR PROFESSIONAL INVESTORS, WHICH HAS THE MEANING ASCRIBED TO IT IN THE SECURITIES AND FUTURES ORDINANCE (CAP. 571 OF THE LAWS OF HONG KONG) AND ITS SUBSIDIARY LEGISLATION. Investment involves risks. Past performance is not indicative of future performance. The information contained in this website is provided for reference only and does not constitute investment advice or an offer or solicitation to buy or sell in any securities or to adopt any investment strategy. Investors should not base their investment decisions solely on the information provided on this website and are advised to seek independent advice (including advice on tax implications) before making any investment decisions. Investors should ensure they fully understand the risks associated with the investment products and should also consider their own investment objectives and risk tolerance level. The investment decision is yours. You should not invest unless the intermediary who sells you the investment products has advised you that it is suitable for you and has explained how it is consistent with your investment objectives. Please refer to the relevant offering documents or other legal documents for further details including the risk factors. This website is published by Robeco Hong Kong Limited which is regulated by the Hong Kong Securities and Futures Commission (“SFC”) (CE No. APU851). This website has not been reviewed by the SFC. No assurance can be given that the investment objective of any investment products will be achieved. No representation or promise as to the performance of any investment products or the return on an investment is made. The value of investments may fluctuate. Past performance, projections, or forecasts included in this website should not be regarded as guarantees or indications of future performance, and no express or implied warranty is provided. The contents of this website are based on sources believed to be reliable, but due to the nature of information delivery technology and the necessity of using multiple data sources, including third party content, their accuracy is not guaranteed. The opinions expressed are as of the date shown above and may change as market conditions evolve, and are subject to change without notice. These opinions may differ from those of other Robeco investment professionals. Robeco accepts no liability for any direct, indirect, or consequential loss arising from the use of this material or any comments, opinions, or estimates contained herein. Robeco has no duty to update this website or any website content. Materials on this website may not be reproduced, distributed, or published without prior written permission from Robeco. Unless otherwise specified, Source: Robeco.
